Literature DB >> 25472920

GC-MS-based plasma metabolomic investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawal.

Ruoxu Liu1, Jianhua Cheng, Jingwen Yang, Xinghua Ding, Shuguang Yang, Fangting Dong, Ning Guo, Shaojun Liu.   

Abstract

Long-term or excessive application of morphine leads to tolerance and addiction, which hindered its conventional applications as a drug. Although tremendous progress has been made on the mechanisms of morphine, crucial evidence elaborating the neurobiological basis of tolerance and dependence is still lacking. To further explore the physiological adaptions during morphine's application, a systematic screening of small molecules in blood has been carried out. The plasma of morphine dependent rats was collected at different time points with or without naloxone treatment, and was analyzed by gas chromatography-mass spectrometry (GC-MS). Partial least squares discriminate analysis (PLS-DA) and the Student's t Tests with the false discovery rate (FDR) correction were conducted on the normalized data for the distinction of groups and the identification of the most contributed metabolites. Clear separation is observed between different treatments, and 29 out of 41 metabolites changes significantly compared with the corresponding controls. The concentration of threonine, glycine, serine, beta-d-glucose and oxalic acid are consistently changed in all morphine treated groups compared with controls. Through this experiment we find characteristic metabolites in different dependent states and discuss the possible compensation effects. The interpretation of these metabolites would throw light on the biological effects of morphine and reveal the possibilities to become marker of morphine addiction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25472920     DOI: 10.1007/s11011-014-9638-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  38 in total

Review 1.  Cellular and synaptic adaptations mediating opioid dependence.

Authors:  J T Williams; M J Christie; O Manzoni
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

2.  Cloning of a delta opioid receptor by functional expression.

Authors:  C J Evans; D E Keith; H Morrison; K Magendzo; R H Edwards
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

3.  Tolerance development to morphine-induced alterations of immune status.

Authors:  J P West; D T Lysle; L A Dykstra
Journal:  Drug Alcohol Depend       Date:  1997-07-04       Impact factor: 4.492

4.  Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse.

Authors:  Y Zhu; M S Hsu; J E Pintar
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

5.  Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract.

Authors:  D Bagnol; A Mansour; H Akil; S J Watson
Journal:  Neuroscience       Date:  1997-11       Impact factor: 3.590

6.  An animal model for opiate induced euphoria and analgesia.

Authors:  C Kornetsky; H S Wheeling
Journal:  Ther Umsch       Date:  1982-08

7.  Metabolomics and its potential in drug development.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Biochem Pharmacol       Date:  2012-08-23       Impact factor: 5.858

8.  Metabolite profiling for plant functional genomics.

Authors:  O Fiehn; J Kopka; P Dörmann; T Altmann; R N Trethewey; L Willmitzer
Journal:  Nat Biotechnol       Date:  2000-11       Impact factor: 54.908

Review 9.  The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence.

Authors:  Lene Martini; Jennifer L Whistler
Journal:  Curr Opin Neurobiol       Date:  2007-12-18       Impact factor: 6.627

10.  Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Authors:  Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; Jesper M Mathiesen; Roger K Sunahara; Leonardo Pardo; William I Weis; Brian K Kobilka; Sébastien Granier
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.